Acting for clients ranging from start-ups through to multinational organisations, Mishcon de Reya LLP covers a plethora of IP issues arising from the life sciences, energy, sports and gaming sectors. Oxford-based Hugh Tebay, who helms the team, is noted for his particular knowledge relating to the commercialisation of IP rights, commercial contracts and licensing matters. Caroline Dry principally focuses on the life sciences sector, and also demonstrates capabilities in the software and space sectors.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘Deep expertise. Very pragmatic. Very reliable.’
- 'Mishcon's intellectual property team provide my company with highest quality Trade Mark, Patent and other IP legal services delivering cost effective solutions in an efficient, professional and business like manner. Mishcon closely guard our global business interests and work alongside me and my team as our trusted advisers.'
- 'The Mishcon IP team embrace our legal needs and share our entrepreneurial, tenacious and enthusiastic approach to building our business. Mishcon's expertise, professionalism and, very important, global standing and reach provide a level of service that would otherwise be more difficult to access.'
Key clients
- Lola Cars Limited/ Lola Formula E Team Limited
- Oxford Innovation Limited
- Perpetual Atomics Limited
- Bockatech Limited
- GMDN Agency
- Atomo Diagnostics linited
- Brill Power Limited
- Carnot Limited
- Turnbull & Asser Limited
- Veer Technologies Limited
- Diosynvax Ltd
Work highlights
Advised Lola Cars / Lola Formula E Team in relation to Formula E racing partnering agreements with Yamaha Motor Company and ABT Sportsline GmbH.
Advised Adsilico Limited on the IP licensing arrangements with Leeds and Manchester Universities in relation to its spinout from Leeds and its subsequent seed round investment.
Advised DIOsynvax Ltd on its engagement with a German technology and service provider, ProBioGen AG, specialising in the development and production of therapeutic biopharmaceuticals.
Practice head
Hugh Tebay
Other key lawyers
Caroline Dry